Cargando…

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma

SIMPLE SUMMARY: Hodgkin lymphoma is the most common malignancy of the lymphatic system, usually affecting young people and with favorable response to treatment. Tailored treatment is important in this patient population to achieve good therapy response while not exposing them to higher treatment rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega, Claudia, Eshet, Yael, Prica, Anca, Anconina, Reut, Johnson, Sarah, Constantini, Danny, Keshavarzi, Sareh, Kulanthaivelu, Roshini, Metser, Ur, Veit-Haibach, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093084/ https://www.ncbi.nlm.nih.gov/pubmed/37046717 http://dx.doi.org/10.3390/cancers15072056

Ejemplares similares

Standardized classification schemes in reporting oncologic PET/CT
por: Murad, Vanessa, et al.
Publicado: (2023)

Corrigendum: Standardized classification schemes in reporting oncologic PET/CT
por: Murad, Vanessa, et al.
Publicado: (2023)

Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
por: Hinzpeter, Ricarda, et al.
Publicado: (2022)

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling
por: Hinzpeter, Ricarda, et al.
Publicado: (2022)

Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma
por: Kulanthaivelu, Roshini, et al.
Publicado: (2022)

Convolutional neural networks for improving image quality with noisy PET data
por: Schaefferkoetter, Josh, et al.
Publicado: (2020)

Prognostic Value of Sarcopenia and Metabolic Parameters of (18)F-FDG-PET/CT in Patients with Advanced Gastroesophageal Cancer
por: Hinzpeter, Ricarda, et al.
Publicado: (2023)

Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic
por: Kohan, Andres, et al.
Publicado: (2023)

Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up
por: Dmytriw, Adam A., et al.
Publicado: (2022)

(18)F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
por: Metser, Ur, et al.
Publicado: (2022)

Disparity and Diversity in NSCLC Imaging and Genomics: Evaluation of a Mature, Multicenter Database
por: Kohan, Andres, et al.
Publicado: (2023)

Imaging of COVID-19 Vaccination at FDG PET/CT
por: Eifer, Michal, et al.
Publicado: (2021)

(18)F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center
por: Metser, Ur, et al.
Publicado: (2021)

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
por: Cheung, Edward, et al.
Publicado: (2021)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017)

Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT
por: Herrmann, Ken, et al.
Publicado: (2015)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study
por: Eifer, Michal, et al.
Publicado: (2022)

Baseline (18)F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2023)

Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
por: Eshet, Yael, et al.
Publicado: (2021)

Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
por: Driessen, Julia, et al.
Publicado: (2023)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
por: Milgrom, Sarah A., et al.
Publicado: (2019)

Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens
por: Geismar, Jan H, et al.
Publicado: (2015)

Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
por: Toyama, Yoshitaka, et al.
Publicado: (2020)

The Impact of Artificial Intelligence CNN Based Denoising on FDG PET Radiomics
por: Jaudet, Cyril, et al.
Publicado: (2021)

Granulomatous Lymphangitis Masquerading as Relapsed Hodgkin Disease on FDG PET/CT
por: Mustafa, Mansour, et al.
Publicado: (2018)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
por: Carles, Montserrat, et al.
Publicado: (2021)

FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial
por: Jones, Michael Peter, et al.
Publicado: (2019)

Assessing radiomic feature robustness to interpolation in (18)F-FDG PET imaging
por: Whybra, Philip, et al.
Publicado: (2019)

Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges
por: Peng, Shichun, et al.
Publicado: (2020)

The Influence of the Exclusion of Central Necrosis on [(18)F]FDG PET Radiomic Analysis
por: Noortman, Wyanne A., et al.
Publicado: (2021)

Occipital Hypometabolism on FDG PET/CT Scan in a Child with Hodgkin's Lymphoma
por: Uslu Biner, Inci, et al.
Publicado: (2016)

[(18)F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
por: Kanoun, Salim, et al.
Publicado: (2018)

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
por: Gallamini, Andrea, et al.
Publicado: (2021)

(18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study
por: Schneider, Paul M., et al.
Publicado: (2018)

International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
por: Veit-Haibach, Patrick, et al.
Publicado: (2023)

Dynamic comparison of PET imaging performance between state-of-the-art ToF-PET/CT and ToF-PET/MR scanners
por: Delso, Gaspar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0gsa5r4hpco69ords9fja5069b